Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 982-986 , August 1995

Insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the kidney of the chronically hypoinsulinemic rat and hyperinsulinemic rat

Received 24 April 1994 ,Accepted 8 December 1994.

References 

  1. Reichard P, Rosenquist U. Nephropathy is delayed by intensified insulin treatment in patients with insulin dependent diabetes mellitus and retinopathy. J Intern Med. 1989;226:81–87
  2. Guler HP, Zapf J, Scheiwiller E, et al.  Recombinant human insulin like growth factor stimulates growth and has direct effects on organ size in hypophysectomized rats. In: ed 6. Proc Natl Acad Sci USA. 85:1988;p. 4889–4893
  3. Guler HP, Eckardt KU, Zapf J, et al.  Insulin-like growth factor increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh). 1989;121:101–106
  4. Guler HP, Schmid C, Zapf J, et al.  Effects of recombinant insulin like growth factor I on insulin secretion and renal function in normal human subjects. In: ed 6. Proc Natl Acad Sci USA. 86:1989;p. 2868–2872
  5. Flyvbjery A, Frystyk J, Thorlacius-Ussing O, et al.  Somatostatin analogue administration prevents increase in kidney somatostatin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia. 1989;32:261–265
  6. Werner H, Shen-Orr Z, Stannard B, et al.  Experimental diabetes increases insulin like growth factor I and II receptor concentrations and gene expression in kidney. Diabetes. 1990;39:1490–1497
  7. Leroith D, Werner H, Phillip M, et al.  The role of insulinlike growth factors in diabetic kidney disease. Am J Kidney Dis. 1993;22:722–726
  8. Gelato MC, Alexander D, Marsh R. Differential tissue regulation of insulin like growth factor binding proteins in experimental diabetes mellitus in the rat. Diabetes. 1992;41:1511–1519
  9. Flyubjerg A, Marshall SM, Frystyk J, et al.  Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion. Kidney Int. 1992;41:805–812
  10. Serri O, Beauregard H, Brazean P, et al.  Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin dependent diabetes. JAMA. 1991;265:888–892
  11. Wang PY. Palmitic acid as an excipient in implants for sustained release of insulin. Biomaterials. 1991;12:57–62
  12. Furlanetto RW, Marino JM. Radioimmunoassay of somatomedin C insulin like growth factor I. Methods Enzymol. 1987;146:216–226
  13. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159
  14. Lowe WL, Schaffner AE, Roberts CT, et al.  Developmental regulation of somatostatin gene expression in brain is region specific. Mol Endocrinol. 1987;1:181–187
  15. Werner H, Woloschak M, Adamo M, et al.  Developmental regulation of the rat insulin like growth factor I receptor gene. In: ed 6. Proc Natl Acad Sci USA. 86:1989;p. 7451–7455
  16. Lowe WL, Lasky SR, Leroith D, et al.  Distribution and regulation of rat insulin like growth factor I mRNA encoding alternative carboxyterminal E peptides: Evidence for differential processing and regulation in liver. Mol Endocrinol. 1988;2:528–535
  17. Lowe WL, Roberts CT, Lasky SR, et al.  Differential expression of alternative 5′ untranslated regions in mRNAs encoding rat insulin like growth factor I. In: ed 6. Proc Natl Acad Sci USA. 84:1987;p. 8946–8950
  18. Doi T, Striker LJ, Elliot SJ, et al.  Insulin like growth factor I is a progression factor for human mesangial cells. Am J Pathol. 1989;134:395–404
  19. Roy S, Sala R, Gagliero E, et al.  Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with memory. In: ed 6. Proc Natl Acad Sci USA. 87:1990;p. 404–408
  20. Ezzat S, Ren SG, Braunstein GD, et al.  Octreotide stimulates insulin like growth factor binding protein 1: A potential pituitary-independent mechanism for drug action. J Clin Endocrinol Metab. 1992;75:1459–1463
  21. Serri O, Brazeau P, Kachraz , et al.  Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: Evidence for a direct and indirect mechanism of action. Endocrinology. 1992;130:1816–1821
  22. Ren SG, Ezzat S, Melmed S, et al.  Somatostatin analog induces insulin-like growth factor binding protein 1 (IGFBP1) expression in human hepatoma cells. Endocrinology. 1992;131:2479–2481
  23. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977–986

PII: 0026-0495(95)90093-4

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 982-986 , August 1995

Article Tools